ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly

CONTEXT: Paltusotine is a once-daily, oral, nonpeptide small-molecule somatostatin receptor type 2 (SST2) agonist in clinical development for treatment of acromegaly. OBJECTIVE: This work aimed to evaluate change in insulin-like growth factor I (IGF-I) levels in patients switched from octreotide lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Monica R, Gordon, Murray B, Doknic, Mirjana, Mezősi, Emese, Tóth, Miklós, Randeva, Harpal, Marmon, Tonya, Jochelson, Theresa, Luo, Rosa, Monahan, Michael, Madan, Ajay, Ferrara-Cook, Christine, Struthers, R Scott, Krasner, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099171/
https://www.ncbi.nlm.nih.gov/pubmed/36353760
http://dx.doi.org/10.1210/clinem/dgac643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099171/
https://www.ncbi.nlm.nih.gov/pubmed/36353760
http://dx.doi.org/10.1210/clinem/dgac643

Ejemplares similares